Our study demonstrated that blocking DHCR7 in the human HCC cell line HepG2 attenuated tumor growth and malignization, indicating that inhibition of DHCR7 in the tumor and/or the tumor microenvironment can produce a strong therapeutic effect on alcohol-induced liver injury and HCC. This evidence concerns the gene DHCR7 and hepatocellular carcinoma.